Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > BioSante Pharmaceuticals to Present at the Susquehanna Healthcare Conference

Abstract:
BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced that Stephen M. Simes, its president and CEO, will present a corporate update and overview at the Susquehanna Financial Group's Second Annual Healthcare Conference, at the W Hotel in New York City. Mr. Simes will present on Wednesday March 5, 2008 at 11:30 a.m. local time. The Susquehanna Conference will feature more than 50 companies presenting to institutional investors, portfolio managers and analysts interested in the biotechnology and pharmaceuticals sectors.

BioSante Pharmaceuticals to Present at the Susquehanna Healthcare Conference

LINCOLNSHIRE, IL | Posted on March 4th, 2008

A live audio webcast of BioSante's presentation at the Susquehanna Conference may be accessed at www.biosantepharma.com/Webcasts.php and a replay will be available at the same link for 60 days.

####

About BioSante Pharmaceuticals, Inc.
BioSante is developing a pipeline of hormone therapy products to treat both men and women. These hormone therapy products are gel formulations for transdermal administration that deliver estradiol and testosterone. BioSante's lead products include LibiGel® (transdermal testosterone gel) in Phase III clinical development by BioSante under a U.S. Food and Drug Administration (FDA) SPA (Special Protocol Assessment) for the treatment of female sexual dysfunction (FSD), and Elestrin™ (estradiol gel) developed through FDA approval by BioSante, indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause, marketed in the U.S. by Nycomed US, BioSante's licensee. Also in development are Bio-T-Gel™, a testosterone gel for male hypogonadism, and an oral contraceptive in Phase II clinical development using BioSante patented technology. The current market in the U.S. for estrogen and testosterone products is approximately $2.5 billion and for oral contraceptives approximately $3.0 billion. The company also is developing its calcium phosphate nanotechnology (CaP) for novel vaccines, drug delivery and aesthetic medicine (BioLook™).

For more information, please click here

Contacts:
McKinney/Chicago
Alan Zachary
(312) 944-6784 ext. 316

www.mckinneychicago.com

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

The random raman laser: A new light source for the microcosmos May 4th, 2015

Defects in atomically thin semiconductor emit single photons: Researchers create optically active quantum dots in 2-D semiconductor for the first time; may have applications for integrated photonics May 4th, 2015

Arrowhead to Report Fiscal 2015 Second Quarter Financial Results May 4th, 2015

From brittle to plastic in 1 breath: Rice University theorists show environments can alter 2-D materials' basic properties May 4th, 2015

Nanomedicine

Arrowhead to Report Fiscal 2015 Second Quarter Financial Results May 4th, 2015

New Nanodrug Produced in Iran from Milk Thistle May 4th, 2015

Antibacterial Ceramic Nanoparticles, Appropriate Material for Medical Devices May 3rd, 2015

Polymeric Nanocarriers Improve Performance of Anticancer Drugs April 30th, 2015

Announcements

Defects in atomically thin semiconductor emit single photons: Researchers create optically active quantum dots in 2-D semiconductor for the first time; may have applications for integrated photonics May 4th, 2015

Arrowhead to Report Fiscal 2015 Second Quarter Financial Results May 4th, 2015

From brittle to plastic in 1 breath: Rice University theorists show environments can alter 2-D materials' basic properties May 4th, 2015

Nanoparticles in consumer products can significantly alter normal gut microbiome May 4th, 2015

Events/Classes

Arrowhead to Report Fiscal 2015 Second Quarter Financial Results May 4th, 2015

Nanometrics to Present at the B. Riley & Co. 16th Annual Investor Conference May 2nd, 2015

No Hogwarts invitation required: Invisibility cloaks move into the real-life classroom: A new solid-state device can demonstrate the physical principles of invisibility cloaks without special equipment or magic spells April 30th, 2015

A phone with the ultimate macro feature: New attachment turns a smartphone into a microscope that can image and size DNA molecules 50,000 times thinner than a human hair April 29th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project